385
Participants
Start Date
July 31, 2009
Primary Completion Date
November 30, 2011
Study Completion Date
November 30, 2014
AZD6244
oral capsules, 75mg twice daily
Dacarbazine
1000 mg/m2 iv infusion over at least 60 min. on day 1 of each 21 cycle
Placebo
Placebo
Research Site, Aurora
Research Site, Boston
Research Site, Belo Horizonte
Research Site, Ijuí
Research Site, Porto Alegre
Research Site, São Paulo
Research Site, Brno
Research Site, Nový Jičín
Research Site, Prague
Research Site, Lille
Research Site, Marseille
Research Site, Villejuif
Research Site, Berlin
Research Site, Essen
Research Site, Hanover
Research Site, Kiel
Research Site, Tübingen
Research Site, Budapest
Research Site, Győr
Research Site, Székesfehérvár
Research Site, Amsterdam
Research Site, Nijmegen
Research Site, Oslo
Research Site, Barcelona
Research Site, Houston
Research Site, Málaga
Research Site, Palma de Mallorca
Research Site, Gothenburg
Research Site, Malmo
Research Site, Stockholm
Research Site, Zurich
Research Site, Cambridge
Research Site, Chelmsford
Research Site, London
Research Site, Manchester
Research Site, Newcastle upon Tyne
Research Site, Oxford
Research Site, Sutton
Lead Sponsor
AstraZeneca
INDUSTRY